PT  - JOURNAL ARTICLE
AU  - Lapidot, Rotem
AU  - Faits, Tyler
AU  - Ismail, Arshad
AU  - Allam, Mushal
AU  - Khumalo, Zamantungwak T.H
AU  - MacLeod, William
AU  - Kwenda, Geoffrey
AU  - Mupila, Zacharia
AU  - Nakazwe, Ruth
AU  - Segrè, Daniel
AU  - Johnson, W. Evan
AU  - Thea, Donald M
AU  - Mwananyanda, Lawrence
AU  - Gill, Christopher J
TI  - Nasopharyngeal Dysbiosis Precedes the Development of Lower Respiratory Tract Infections in Young Infants, a Longitudinal Infant Cohort Study
AID  - 10.1101/2021.10.13.21264939
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.10.13.21264939
4099  - http://medrxiv.org/content/early/2021/10/15/2021.10.13.21264939.short
4100  - http://medrxiv.org/content/early/2021/10/15/2021.10.13.21264939.full
AB  - Background Infants suffering from lower respiratory tract infections (LRTIs) have distinct nasopharyngeal (NP) microbiome profiles that correlate with severity of disease. Whether these profiles precede the infection or a consequence of it, is unknown. In order to answer this question, longitudinal studies are needed.Methods We conducted an analysis of a longitudinal prospective cohort study of 1,981 Zambian mother-infant pairs who underwent NP sampling from 1-week through 14-weeks of age at 2-3-week intervals. Ten of the infants in the cohort developed LRTI and were matched 3:1 with healthy comparators. We completed 16S rRNA gene sequencing on the samples each of these infants contributed, as well as from baseline samples of the infants’ mothers, and characterized the normal maturation of the healthy infant NP microbiome, compared to infants who developed LRTI.Results The infant NP microbiome maturation was characterized by transitioning from Staphylococcus dominant to respiratory-genera dominant profiles during the first three months of life, similar to what is described in the literature. Interestingly, infants who developed LRTI had NP dysbiosis before infection, in most cases as early as the first week of life. Dysbiosis was characterized by the presence of Novosphingobium, Delftia, high relative abundance of Anaerobacillus, Bacillus, and low relative abundance of Dolosigranulum, compared to the healthy controls. Mothers of infants with LRTI also had low relative abundance of Dolosigranulum in their baseline samples compared to mothers of infants that did not develop an LRTI.Conclusions Our results suggest that NP microbiome dysbiosis precedes LRTI in young infants and may be present in their mothers as well. Early dysbiosis may play a role in the causal pathway leading to LRTI or could be a marker of other pathogenic forces that directly lead to LRTI.Funding This work was supported by The Southern Africa Mother Infant Pertussis Study – Nasopharyngeal Carriage (SAMIPS-NPC). PI Gill. Funder NIH/NIAID (1R01AI133080). WEJ and TF were supported by funds from the NIH, U01CA220413 and R01GM127430.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialN/AClinical Protocols N/A Funding StatementThis work was supported by The Southern Africa Mother Infant Pertussis Study - Nasopharyngeal Carriage (SAMIPS-NPC). PI Gill. Funder NIH/NIAID (1R01AI133080). WEJ and TF were supported by funds from the NIH, U01CA220413 and R01GM127430.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the ethical review committees at the ERES Converge IRB in Lusaka, Zambia, and at Boston University Medical Center. All mothers provided written informed consent, with consent provided in English, Bemba or Nyanja as preferred by the participant.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.Not ApplicableI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Not ApplicableThe raw and processed sequencing data from this study are available in the SRA repository, under accession number pending. Furthermore, all code, processed data, and the sample information metadata are available in the following GitHub repository: https://github.com/tfaits/Infant_Nasopharyngeal_Dysbiosis. Taxon counts tables are called "species.RDS", "genus.RDS", and "phylum.RDS". For strain/subspecies-level counts, "PathoScopeTable.txt" has the unfiltered/unprocessed outputs from PathoScope. https://github.com/tfaits/Infant_Nasopharyngeal_Dysbiosis